Canada’s prescription drug spending slowing


Canada was expected to spend $28.8 billion on prescription drugs by 2014, but the country didn’t reach that mark until 2015. The country’s rate of prescription drug spending is slowing because of savings from generics and recent patent expirations. However, expensive biologics are still driving up costs, as some overly expensive biologics can cost as much as hundreds of thousands of dollars per patient. Healthcare experts expect biosimilars to drive down some of those costs over time.


Read the source article at

About the Author

Related Posts

Leave a Reply